Effectiveness and safety of antifibrinolytic agents in the management of pulmonary haemorrhage: A systematic review with narrative synthesis

doi:10.12998/wjcc.122847

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 24

This Article

(0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Aug 26, 2026; 14(24): 122847
Published online Aug 26, 2026. doi: 10.12998/wjcc.122847

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA flow diagram of study identification, screening, eligibility assessment, and inclusion.

Open in New Tab Full Size Figure Download Figure

Figure 2 Risk of bias traffic-light plot for included studies.

Open in New Tab Full Size Figure Download Figure

Figure 3 Summary risk of bias plot across included studies.

Citation: Kabir Y, Soldera J. Effectiveness and safety of antifibrinolytic agents in the management of pulmonary haemorrhage: A systematic review with narrative synthesis. World J Clin Cases 2026; 14(24): 122847
URL: https://www.wjgnet.com/2307-8960/full/v14/i24/122847.htm
DOI: https://dx.doi.org/10.12998/wjcc.122847